Cart
sales@molnova.com
DDD107498
CAS No. 1469439-69-7
DDD107498 ( DDD498;M 5717;MMV121 )
Catalog No. M20149 CAS No. 1469439-69-7
DDD107498 has a potent and novel spectrum of antimalarial activity against multiple life-cycle stages of the Plasmodium parasite. It targets translation elongation factor 2 (eEF2).
Purity : >98% (HPLC)
COA
Datasheet
HNMR
HPLC
MSDS
Handing Instructions
| Size | Price / USD | Stock | Quantity |
| 5MG | 349 | In Stock |
|
| 10MG | 547 | In Stock |
|
| 25MG | 931 | In Stock |
|
| 100MG | Get Quote | In Stock |
|
| 200MG | Get Quote | In Stock |
|
| 500MG | Get Quote | In Stock |
|
| 1G | Get Quote | In Stock |
|
Biological Information
-
Product NameDDD107498
-
NoteResearch use only not for human use.
-
Brief DescriptionDDD107498 has a potent and novel spectrum of antimalarial activity against multiple life-cycle stages of the Plasmodium parasite. It targets translation elongation factor 2 (eEF2).
-
DescriptionDDD107498 has a potent and novel spectrum of antimalarial activity against multiple life-cycle stages of the Plasmodium parasite. It targets translation elongation factor 2 (eEF2).
-
SynonymsDDD498;M 5717;MMV121
-
PathwayMicrobiology/Virology
-
TargetParasite
-
RecptoreEF2
-
Research AreaOthers
-
IndicationMalaria
Chemical Information
-
CAS Number1469439-69-7
-
Formula Weight462.57
-
Molecular FormulaC27H31FN4O2
-
Purity>98% (HPLC)
-
SolubilityDMSO:10 mM
-
SMILESFc1ccc2nc(cc(C(=O)NCCN3CCCC3)c2c1)-c1ccc(CN2CCOCC2)cc1
-
Chemical Name——
Shipping & Storage Information
-
Storage(-20℃)
-
ShippingWith Ice Pack
-
Stability≥ 2 years
Reference
1.Baraga?a B et al. A novel multiple-stage antimalarial agent that inhibits protein synthesis. Nature. 2015 Jun 18;522(7556):315-20.
molnova catalog
related products
-
Antimalarial agent 1
Antimalarial agent 1 is an effective antimalarial agent.
-
SJ-733
SJ-733 (SJ000557733;SJ-557733) is an anti-malarial compound that targets ATP4, a cation-transporting ATPase responsible for maintaining low intracellular Na(+) levels in the parasite.
-
Ganaplacide
Ganaplacide (KAF156, GNF-156)is a novel antimalarial clinical candidate that shows blood schizonticidal activity with IC50 of 6-17.4 nM against P falciparum drug-sensitive and drug-resistant strains.
